Skip to content
OpenCapital
Get started

Hyperfine, Inc. HYPR Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By geography

See full
Non Us18.6%-63.0%

Other financials

Income statement

See full
Revenue$3.9M+82.6%
Gross profit$2.0M+124%
Operating income-$8.6M+21.5%
Net income-$8.6M+8.4%
EPS (diluted)-$0.09+25.0%

Balance sheet

See full
Cash & equivalents$40.8M+23.2%
Total debt$13.4M+4,977%
Total equity$34.4M-20.3%
Total assets$60.3M+13.0%

Cash flow

See full
Operating cash flow-$9.0M+2.6%
CapEx$242.0K-48.7%
Free cash flow-$9.3M+4.8%

Valuation

See full
Market cap$129.05M+127%
Enterprise value$101.63M+220%
P/S8.4×+3.1×

Profitability

See full
Gross margin51.2%+5.0pp
Operating margin-226.6%-63.4pp
Net margin-226.9%-57.5pp
FCF margin-187%-52.9pp

Returns & leverage

See full
Return on equity-89.8%+42.9pp
Debt / equity0.4×+0.4×
Current ratio5.5×-0.5×